Aimei Health Technology Co., Ltd. SEC filings AFJKR
Aimei Health Technology Co., Ltd. has 125 filings in SEC EDGAR's recent list, going back to May 26, 2023. Its latest annual report, Form 10-K, was filed on May 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (new debt). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
New debt
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K/A |
Amended current report
New debt
|
Nov 3, 2026 | Oct 5, 2026 |
| 8-K |
Current report
New debt
|
Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
New debt
|
Sep 3, 2026 | Sep 3, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 25, 2026 | Aug 21, 2026 |
| 8-K |
Current report
New debt
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Jul 8, 2026 | Jul 7, 2026 |
| 8-K |
Current report
New debt
|
Jul 6, 2026 | Jul 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 29, 2026 | Jun 24, 2026 |
| 8-K |
Current report
New debt
|
Jun 4, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Listing notice
|
May 20, 2026 | May 19, 2026 |
| 8-K |
Current report
New debt
|
May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Listing notice
|
Apr 21, 2026 | Apr 17, 2026 |
| 8-K |
Current report
New debt
|
Apr 7, 2026 | Apr 7, 2026 |
| 8-K |
Current report
New debt
|
Mar 4, 2026 | Mar 4, 2026 |
| 8-K |
Current report
New debt
|
Feb 13, 2026 | Feb 12, 2026 |
| 8-K |
Current report
New debt
|
Jan 6, 2026 | Jan 5, 2026 |
| 8-K |
Current report
New debt
|
Dec 8, 2025 | Dec 5, 2025 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Dec 2, 2025 | Nov 26, 2025 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Nov 12, 2025 | Nov 6, 2025 |
| 8-K |
Current report
New debt
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
New debt
|
Oct 9, 2025 | Oct 8, 2025 |
| 8-K |
Current report
New debt
|
Sep 5, 2025 | Sep 5, 2025 |
| 8-K |
Current report
New debt
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
New debt
|
Jul 7, 2025 | Jul 6, 2025 |
| 8-K |
Current report
Material agreement
|
Jun 11, 2025 | Jun 6, 2025 |
| 8-K |
Current report
New debt
|
Jun 6, 2025 | Jun 6, 2025 |
| 8-K |
Current report
New debt
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
New debt
|
Apr 7, 2025 | Apr 4, 2025 |
| 8-K |
Current report
New debt
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Material agreement, New debt, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Feb 7, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Feb 4, 2025 | Feb 4, 2025 |
| 8-K |
Current report
New debt
|
Jan 14, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Dec 31, 2024 | Dec 23, 2024 |
| 8-K |
Current report
New debt
|
Dec 13, 2024 | Dec 11, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 20, 2024 | Jun 19, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 19, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Other events
|
Jan 18, 2024 | Jan 18, 2024 |
| 8-K |
Current report
Other events
|
Dec 12, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Dec 7, 2023 | Dec 6, 2023 |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- AFJK (Nasdaq), AFJKR (Nasdaq), AFJKU (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1979005
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Source: SEC EDGAR filings. This is company-reported data, not investment advice.